版本:
中国

BRIEF-Cerus provides update on U.S. Platelet additive solution supply

June 7 Cerus Corp:

* Cerus provides update on U.S. Platelet additive solution (pas) supply

* Cerus Corp - expected Fresenius Kabi pas shortage could be less disruptive to blood center production of intercept platelets than initially anticipated

* Cerus Corp - "cautiously optimistic that a future supply shortage for our customers has been mitigated by FDA decision"

* Cerus - expectation follows decision by FDA to review a recent submission by Fresenius Kabi as a changes being effected in 30 days (cbe-30) supplement Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐